Effect of a probiotic on blood pressure in grade 1 hypertension (HYPRO): protocol of a randomized controlled study
Abstract Background Arterial hypertension is a major risk factor for cardiovascular disease and leads to target organ damage including stroke, heart failure, and kidney disease. About 1.5 billion people worldwide have hypertension, and it is estimated that it causes about 8 million deaths each year....
Main Authors: | Anja Mähler, Nicola Wilck, Geraldine Rauch, Ralf Dechend, Dominik N. Müller |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-020-04973-0 |
Similar Items
-
Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0–2-month-old low birth weight infants in India—the “ProSPoNS” Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trial
by: Anju Pradhan Sinha, et al.
Published: (2021-04-01) -
Short-Term Probiotic Administration Increases Fecal-Anti <i>Candida</i> Activity in Healthy Subjects
by: Massimiliano De Angelis, et al.
Published: (2019-06-01) -
The Application of Metabolomics to Probiotic and Prebiotic Interventions in Human Clinical Studies
by: Thomas M. O’Connell
Published: (2020-03-01) -
Butyrate Producers as Potential Next-Generation Probiotics: Safety Assessment of the Administration of Butyricicoccus pullicaecorum to Healthy Volunteers
by: Leen Boesmans, et al.
Published: (2018-11-01) -
Changes in the gut microbiome and metabolome in a rat model of pulmonary arterial hypertension
by: Wei Hong, et al.
Published: (2021-01-01)